Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bharat Biotech, ICMR announce interim results from Phase 3 trials of COVAXIN
It demonstrates overall interim clinical efficacy of 78 per cent and 100 per cent efficacy against severe COVID-19 disease
Pharma firms with approval for projects under PLI scheme should start production at the earliest:…
This will enable India to provide pharma and medical devices products to domestic and global markets at competitive rates
India to waive 10 per cent import duty on COVID-19 vaccines: Govt source
Imports of Russia's Sputnik V vaccine are due to arrive soon and the government has also urged Pfizer, Moderna and Johnson and…
ISSAR Pharma announces out-licensing of its peptide-based NCEs
ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as…
Chair’s Address: Chakravarthi AVPS, Global Ambassador, World Packaging Organisation
PPL Conclave 2021 | Virtual Conference | Tues, 20th April 2021 | 10:00 AM - 6:30 PM IST
Special Address: Professor Pierre Pienaar, President, World Packaging Organisation
PPL Conclave 2021 | Virtual Conference | Tues, 20th April 2021 | 10:00 AM - 6:30 PM IST
High quality elastomeric components for generics and safety devices for injectable drugs: Vikrant…
PPL Conclave 2021 | Virtual Conference | Tues, 20th April 2021 | 10:00 AM - 6:30 PM IST
Cold chain tracking within vaccine packaging: Torsten Sauer, Head of Digital Sales, Uhlmann…
PPL Conclave 2021 | Virtual Conference | Tues, 20th April 2021 | 10:00 AM - 6:30 PM IST
Panel Discussion: The COVID-19 impact on packaging
PPL Conclave 2021 | Virtual Conference | Tues, 20th April 2021 | 10:00 AM - 6:30 PM IST
Bharat Biotech announces COVAXIN capacity expansion
Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for COVAXIN